GreenMark Secures Additional Funding for Cavity Identification and Treatment

East Lansing & Ann Arbor, MI — GreenMark Biomedical Inc. today announced it secured $670K equity funding completing a $1.2M Series Seed Preferred Stock round to further develop and commercialize its patented nanoparticle-based dental technology. The University of Michigan’s MINTS program, Invest Michigan and Red Cedar Ventures investments follow earlier funding from Blue Water Angels, Western Michigan University's BRCC and Invest Detroit Ventures. GreenMark’s products, which are being developed by GreenMark with collaborators at the University of Michigan, quickly identify early dental ‘pre-cavities’ that can be treated non-invasively to prevent the formation of cavities. The technology utilizes bioresorbable starch-based nanoparticles which degrade into harmless materials by the time the patient is ready to leave the dental office. [Read the full news release here.]